Medication | Patients on drug group, n (%) | Patients on drug class, n (%) | Patients adequately dosed per class as per WHO-DDD, n (%) |
---|---|---|---|
Diuretics | 614 (95) | ||
Thiazides | 424 (65) | 181 (43) | |
Loop | 235 (36) | 150 (64) | |
Potassium sparing | 50 (8) | 1 (2) | |
Mineralocorticoid antagonists | 48 (7) | 5 (10) | |
Renin–angiotensin–aldosterone system (RAAS) | 614 (95) | ||
ACE-inhibitors | 286 (44) | 267 (93) | |
Angiotensin receptor blockers | 320 (49) | 305 (95) | |
Direct renin inhibitors | 5 (1) | 5 (100) | |
HR reducers | 440 (68) | ||
Beta-blockers | 412 (63) | 130 (31) | |
Calcium channel blockers — non dihydropyridines | 41 (5) | 11 (27) | |
CCB-DHP | 440 (68) | ||
Calcium channel blockers — dihydropyridines | 429 (68) | 424 (99) | |
Vasodilators | 129 (20) | ||
Alpha-blockers | 127 (19) | 124 (98) | |
Other vasodilators | 3 (1) | 0 (0) | |
Centrally acting | 2 (<1) | ||
Centrally acting drugs | 2 (1) | 0 (0) |
ACE = angiotensin-converting enzyme. CCB-DHP = calcium channel blockers — non-dihydropyridines. HR = heart rate. WHO-DDD = World Health Organization-defined daily dosing.